WEDNESDAY, June 10, 2026 (HealthDay News) -- For adults with type 2 diabetes (T2D) that is inadequately controlled with diet and exercise alone, retatrutide, a triple hormone receptor agonist, is associated with significant improvements in glycemic control and body weight reductions, according to a study published online June 6 in The Lancet to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Harpreet S
Patients should be advised to monitor their blood glucose levels if they have access to home testing equipment
These shifts typically normalize as your weight stabilizes, and many fertility specialists view the eventual metabolic improvement as beneficial for conception chances
Patients on Mounjaro plus an SGLT2 inhibitor will pee substantially more due to glucose excretion in urine
Find The Right Weight Care Plan With Mochi Health Navigating many treatment options and nuances within weight management care can be daunting
UCLA Health notes that people taking GLP-1 drugs may experience side effects such as nausea, vomiting, constipation, and appetite changes